Home The Word Brain My Amedeo FAQ Privacy About   


Amedeo C49

English + 你好 (nǐ hǎo) = limitless possibilities.
Start learning Mandarin Chinese today—for free, forever.

Amedeo C49 is completely free, for life. Next week: +49.


  Urinary Tract Infection, October 2025

Free Subscription


Abstracts

Retrieve all available abstracts of the following 148 articles:
HTML format


 

Single Articles

  1. LIU Y, Yang Z, Xiang Y, Cheng G, et al
    Single-cell analysis reveals an important role of CD137L+ macrophages in the host response to uropathogenic Escherichia coli infection in the bladder.
    PLoS Pathog. 2025;21:e1013543.
    PubMed    
    Abstract available

  2. SATO Y, Hatayama N, Suzuki Y, Yugeta N, et al
    Urinary tract infection due to Staphylococcus schleiferi biofilm formation in the subcutaneous ureteral bypass system in a cat.
    BMC Vet Res. 2025;21:566.
    PubMed    
    Abstract available

  3. SEELUANGSAWAT A, Sowanthip D, Opanuraks J, Santingamkun A, et al
    Effect of antibiotic prophylaxis after flexible cystoscopy to prevent symptomatic urinary tract infection: a randomized controlled trial.
    BMC Infect Dis. 2025;25:1226.
    PubMed    


  4. BROOKSHIRE WC, Ballard L, Collinsgru A, Burnette J, et al
    Evaluation of a Rapid, Low-Cost Broth Turbidity Test for Detecting Ampicillin-Resistant Lower Urinary Tract Infections in Dogs and Cats.
    J Vet Intern Med. 2025;39:e70259.
    PubMed    
    Abstract available

  5. ELLISON JS
    Commentary - Management of paediatric urinary tract infections in 2025: Where do we go from here?
    J Pediatr Urol. 2025 Sep 30:S1477-5131(25)00473.
    PubMed    


  6. ARAKKAL S, Lakshman R
    Urinary tract infection (recurrent): antimicrobial prescribing (NICE NG112).
    Arch Dis Child Educ Pract Ed. 2025 Oct 1:edpract-2025-328991.
    PubMed    


  7. AHMED F, Alhamdani E, Al-Wageeh S, Alyhari Q, et al
    Epidemiology and antimicrobial resistance of uropathogens in a tertiary care setting in Yemen: a retrospective study.
    Arch Ital Urol Androl. 2025;97:14129.
    PubMed    
    Abstract available

  8. MUSAMEH I, Mohsen ZA, Mohamed A
    Use of mebendazole (anthelmintic) for recurrent uncomplicated urinary tract infections in a healthy female: A case report.
    Qatar Med J. 2025;2025:92.
    PubMed    
    Abstract available

  9. GANGULY A, Basu U, Gunda V, Krishnan A, et al
    USENSE: A proof-of-concept self-screening tool for home-based recurrent urinary tract infection management.
    Bioeng Transl Med. 2025;10:e70038.
    PubMed    
    Abstract available

  10. WANG Y, Chen Y, Zhang X, Zhang J, et al
    Postoperative bladder training in patients with mid-low rectal cancer facilitates early removal of the urinary catheter: a prospective, randomized, open-label, blinded-endpoint trial.
    World J Surg Oncol. 2025;23:353.
    PubMed    
    Abstract available

  11. AREF M, Fathi J, Ghazanfari P, Malekzadegan Y, et al
    Characterization of plasmid-mediated quinolone resistant genes among uropathogenic Escherichia coli isolates in Bushehr, south of Iran.
    BMC Res Notes. 2025;18:404.
    PubMed    
    Abstract available

  12. GNECH M, Bujons A, Radmayr C, 't Hoen L, et al
    Response to management of paediatric urinary tract infections in 2025: Where do we go from here? A commentary on "Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children" on behalf of the EAU/ESPU paediatric uro
    J Pediatr Urol. 2025 Sep 29:S1477-5131(25)00472.
    PubMed    


  13. RUSTIA G, Abrams M, Rhodes S, Hijaz A, et al
    Inpatient Mortality Among U.S. Women Treated for Urinary Tract Infection 2016-2020.
    Urogynecology (Phila). 2025 Sep 29. doi: 10.1097/SPV.0000000000001756.
    PubMed    
    Abstract available

  14. HJELHOLT AJ, Hjelholt TJ, Azuz S
    [Pharmacological prevention of recurrent urinary tract infections].
    Ugeskr Laeger. 2025;187:V01250039.
    PubMed    
    Abstract available

  15. MURAD MW, Poran GMS, Baidya K, Ahsan N, et al
    Genomic Characterization of Pan-Drug Resistant Klebsiella pneumoniae KPNW Isolated From UTI Patient in Bangladesh.
    Microbiologyopen. 2025;14:e70064.
    PubMed    
    Abstract available

  16. JEON BJ, Ko YJ, Park JY, Bae JH, et al
    Correlating Urinary Tract Infection Risks With Sodium-Glucose Cotransporter-2 Inhibitors: Insights From the National Health Insurance Data of Korea.
    J Korean Med Sci. 2025;40:e244.
    PubMed    
    Abstract available

  17. KIM C, Roh YN
    Renal Artery Bypass and Both Renal Vein Reimplantation for Acute Onset Renal Artery Aneurysm Following Urinary Tract Infection: A Case Report.
    Vasc Specialist Int. 2025;41:28.
    PubMed    
    Abstract available

  18. MERMER S, Akyol D, Ozkara MB, Aydemir SS, et al
    Cefixime-clavulanic acid in ESBL-producing E. coli lower urinary tract infections: a 13-patient case series.
    BMC Infect Dis. 2025;25:1218.
    PubMed    
    Abstract available

  19. ZHANG M, Wei N, Lin R, Xu Y, et al
    Deferoxamine addresses metabolic dysregulation and urinary tract infections in weight-associated gestational diabetes mellitus.
    Eur J Med Res. 2025;30:897.
    PubMed    
    Abstract available

  20. BELVONCIKOVA P, Gardlik R
    Faecal microbiota transplantation for urinary tract infections.
    Clin Microbiol Infect. 2025 Sep 27:S1198-743X(25)00469.
    PubMed    
    Abstract available

  21. BOMBA J, Hebb A
    Streamlining to Zero: Operational Excellence for CAUTI Prevention.
    Crit Care Nurs Q. 2025;48:414-418.
    PubMed    
    Abstract available

  22. GEBREMEDHIN KB, Amogne W, Alemayehu H, Bopegamage S, et al
    The role of uropathogenic Escherichia coli virulence factors in the development of urinary tract infection.
    J Med Life. 2025;18:701-709.
    PubMed    
    Abstract available

  23. ABBAS KF, Motaweq ZY
    Detection of Vancomycin Resistance Enterococcus Species Holding Genes vanA, vanB, vanC1, vanC2, and vanC3 Isolated from Urinary Tract Infections.
    Biochem Genet. 2025 Sep 27. doi: 10.1007/s10528-025-11222.
    PubMed    
    Abstract available

  24. ANORUE M, Ejikeugwu C, Iroha CS, David EE, et al
    Extended spectrum beta-lactamase producing Escherichia coli encoding aminoglycoside and fluoroquinolone resistant genes in urinary tract infection patients in a tertiary hospital in Nigeria.
    BMC Infect Dis. 2025;25:1171.
    PubMed    
    Abstract available

  25. ULLAH Z, Asghar J, Aziz N, Ullah A, et al
    Bacterial profiling and antibiotic resistance patterns in urinary tract infections: a microbiological analysis from Dera Isamil Khan, Pakistan.
    BMC Infect Dis. 2025;25:1151.
    PubMed    
    Abstract available

  26. GOLEANU VASILOIU CD, Vrancianu CO, Goleanu DA, Tantu MM, et al
    Trends in Antibiotic Resistance of Escherichia coli Strains Isolated from Clinical Samples (2019-2023): A Hospital-Based Retrospective Analysis.
    Pathogens. 2025;14:927.
    PubMed    
    Abstract available

  27. DRAGOESCU PO, Grigorescu BL, Stanculescu AD, Panus A, et al
    The Diagnostic and Prognostic Value of Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Urosepsis.
    Medicina (Kaunas). 2025;61:1713.
    PubMed    
    Abstract available

  28. CHENG TH, Lu W, Chen CB, Seak CJ, et al
    Risk Factors and Development of a Predictive Model for In-Hospital Mortality in Hemodynamically Stable Older Adults with Urinary Tract Infection.
    Medicina (Kaunas). 2025;61:1625.
    PubMed    
    Abstract available

  29. BANDAC CA, Ristescu C, Onofrei P, Miftode IL, et al
    Assessment of Factors Contributing to Multidrug Resistance in Urinary Tract Infections: Focus on Carbapenem Resistance.
    Antibiotics (Basel). 2025;14:918.
    PubMed    
    Abstract available

  30. PACURAR D, Dinulescu A, Totu AV, Dijmarescu I, et al
    Escherichia coli Urinary Tract Infections from a Romanian Pediatric Hospital: Antimicrobial Resistance Trends, ESBL Prevalence, and Empirical Treatment Implications.
    Antibiotics (Basel). 2025;14:855.
    PubMed    
    Abstract available

  31. FILEV R, Bogov B, Lyubomirova M, Rostaing L, et al
    From Pandemic to Resistance: Addressing Multidrug-Resistant Urinary Tract Infections in the Balkans.
    Antibiotics (Basel). 2025;14:849.
    PubMed    
    Abstract available

  32. TEGEGNE DT, Abbott IJ, Pozniak B
    Catheter-Associated Urinary Tract Infections: Understanding the Interplay Between Bacterial Biofilm and Antimicrobial Resistance.
    Int J Mol Sci. 2025;26:9193.
    PubMed    
    Abstract available

  33. VARGAS CEF, Mutarelli A, Menegardo LG, Silva AKBD, et al
    Efficacy of D-mannose as prophylaxis of recurrent urinary tract infection: a systematic review and meta-analysis of randomized controlled trials.
    J Bras Nefrol. 2025;47:e20250169.
    PubMed    
    Abstract available

  34. BOATENG E, Owusu H, Thekkur P, Hedidor GK, et al
    Operational Research Improves Compliance with Treatment Guidelines for Empirical Management of Urinary Tract Infection: A Before-and-After Study from a Primary Health Facility in Ghana.
    Trop Med Infect Dis. 2025;10:259.
    PubMed    
    Abstract available

  35. LI J, Wang Z, Zheng R, Wang Y, et al
    Identification, antifungal resistance, and genomic characterization of a single Candida auris isolate from urinary tract infection.
    Front Cell Infect Microbiol. 2025;15:1641542.
    PubMed    
    Abstract available

  36. FLURY D, Glampedakis E, Bloch N, Gardiol C, et al
    First nationwide point-prevalence survey on healthcare-associated infections and antibiotic use in long-term care facilities, Switzerland, September 2024.
    Euro Surveill. 2025;30:2500221.
    PubMed    
    Abstract available

  37. YEH FS, Wu CW, Huang MH, Chen KC, et al
    Influence of prophylactic antibiotics on incidence of urinary tract infections in acute-to-subacute patients with stroke and asymptomatic bacteriuria.
    Sci Rep. 2025;15:32787.
    PubMed    
    Abstract available

  38. TIKKINEN KAO, Tadayon Najafabadi B, Hajebrahimi S, Tondroanamag F, et al
    A Multicenter Randomized Controlled Trial of Antimicrobial Prophylaxis to Prevent Urinary Tract Infections after Shockwave Lithotripsy for Urolithiasis: The APPEAL Trial.
    Eur Urol. 2025 Sep 24:S0302-2838(25)00506-8. doi: 10.1016/j.eururo.2025.
    PubMed    
    Abstract available

  39. FERNANDEZ-GARCIA S, Moragas A, Giner-Soriano M, Morros R, et al
    Urinary tract infections in women in Catalonia, Spain: a population-based observational cohort study in primary care.
    Front Pharmacol. 2025;16:1593910.
    PubMed    
    Abstract available

  40. HUSSAIN D, Barnwal J
    Correction: Association between urinary tract infections and anemia among the elderly in India: Insights from the longitudinal aging study.
    PLOS Glob Public Health. 2025;5:e0005239.
    PubMed    
    Abstract available

  41. DOKE PP, Gothankar JS, Chutke AP
    The untold story of elimination of human schistosomiasis from Gimavi village, Ratnagiri district, Maharashtra State, India: A qualitative study.
    Indian J Med Res. 2025;162:5-13.
    PubMed    
    Abstract available

  42. NGUYEN THP, Young BR, Bornstein LM, Samiezade-Yazd Z, et al
    Prevalence of Serious Infection Among Hypothermic Young Infants Across Medical Settings.
    Hosp Pediatr. 2025;15:795-803.
    PubMed    
    Abstract available

  43. APARICIO COLL A, Algarrada Vico L, Rigalos Cases A, Trenchs Sainz de la Maza V, et al
    Invasive bacterial infection in febrile neonates with influenza infection.
    An Pediatr (Engl Ed). 2025;103:503966.
    PubMed    
    Abstract available

  44. BHOJANI N, Morris K, White J, Rojanasarot S, et al
    Post-operative infection with a single-use ureteroscope with real-time intrarenal pressure monitoring vs. all other single-use ureteroscopes.
    Expert Rev Med Devices. 2025;22:1135-1143.
    PubMed    
    Abstract available

  45. HOVHANNISYAN VA, Bazukyan IL, Gasparyan VK
    Lectin based immunochromatographic assay for detection of kidney infections.
    Diagn Microbiol Infect Dis. 2026;114:117076.
    PubMed    
    Abstract available

  46. MAHALILA MP, Angelo T, Kinung'hi S, Civitello DJ, et al
    A case of schistosomiasis and healthcare seeking in Mwanza, Tanzania.
    Trends Parasitol. 2025;41:825-828.
    PubMed    
    Abstract available

  47. BAJRACHARYA S, Basnet A, Shrestha RB, Adhikari J, et al
    A Retrospective Analysis of Bacterial Infections (2021-2024) in a Reference Laboratory in Kathmandu, Nepal.
    Am J Trop Med Hyg. 2025;113:749-757.
    PubMed    
    Abstract available

  48. VERSCHOOR CP, Cerasuolo JO, Caswell JM, Tatangelo M, et al
    Respiratory Syncytial Virus (RSV)-Related Hospitalization and Increased Rate of Cardiovascular Events in Older Adults.
    J Am Geriatr Soc. 2025 Jul 23. doi: 10.1111/jgs.19591.
    PubMed    
    Abstract available

  49. PRIYADARSHI N, Garg P, Bhumij M, Sagar P, et al
    Bioinspired Plasmonic Glyconanosensors for Onsite Optical Detection of Uropathogenic Escherichia coli in Urine Samples.
    ACS Sens. 2025;10:6521-6532.
    PubMed    
    Abstract available

  50. SELVI I, Donmez MI, Baydilli N, Quirroz Madarriaga Y, et al
    Factors associated with pregnancy related complications in women with a history of vesicoureteral reflux: A systematic review by the EAU-YAU Paediatric Urology Working Group.
    Actas Urol Esp (Engl Ed). 2025;49:501821.
    PubMed    
    Abstract available

  51. OGASAWARA RA, Yajima S, Imasato N, Kanagawa T, et al
    Role of cystatin C-based sarcopenia index in predicting postoperative infectious complications after major urologic cancer surgery.
    Int J Clin Oncol. 2025;30:2087-2094.
    PubMed    
    Abstract available

  52. YAZILITAS F, Ozlu SG, Aydog O, Bulbul M, et al
    Voiding cystourethrography practices: experiences in a tertiary pediatric referral hospital.
    Acta Radiol. 2025;66:1077-1084.
    PubMed    
    Abstract available

  53. NOORI W, Sibley CT, Chirikov VV, Roney K, et al
    Risk of Cardiovascular Events, Infections, and Renal Complications in Postsurgical Chronic Hypoparathyroidism: A US Medicare Claims Retrospective Analysis.
    Adv Ther. 2025;42:4866-4880.
    PubMed    
    Abstract available

  54. BAIN M, Couchman M', Rutherford C, Kirchmann M, et al
    Cost-effectiveness analysis of hydrophilic coated catheters for intermittent catheterisation in traumatic spinal cord injury in New Zealand.
    ANZ J Surg. 2025;95:1917-1922.
    PubMed    
    Abstract available

  55. LAGROU J, Jourdain S, Smeesters PR, Roggen I, et al
    Invasive and urinary tract infections in febrile neonates in the emergency department: a retrospective analysis.
    Eur J Pediatr. 2025;184:674.
    PubMed    
    Abstract available

  56. VAZQUEZ C, Perdiguero GG, Ballerga EG, Ivirico ISP, et al
    Prospective surveillance reveals high rates of antimicrobial resistance in urinary tract infections among patients with cirrhosis.
    Ann Hepatol. 2025 Oct 8:102135. doi: 10.1016/j.aohep.2025.102135.
    PubMed    
    Abstract available

  57. IMZHAROV T, Zhakiev B, Sarkulov M, Pavlov V, et al
    THE EFFECTIVENESS OF METAPHYLAXIS OF NEPHROLITHIASIS DURING PERCUTANEOUS NEPHROLITHOTRIPSY: A SYSTEMATIC REVIEW AND METAANALYSIS.
    Georgian Med News. 2025;.
    PubMed    
    Abstract available

  58. ZHANG J, Wen S, Chen L, Qin J, et al
    Analysis of the microbial spectrum of urinary tract infections and antibiotic resistance of UPEC in Central Inner Mongolia, China.
    Front Microbiol. 2025;16:1599902.
    PubMed    
    Abstract available

  59. KARAMI A, Majedi MA, Kamyari N, Vatandost S, et al
    Correlation between nurses' knowledge and practices in prevention of catheter-associated urinary tract infection (CAUTI) with UTI incidence in ICU.
    BMC Nurs. 2025;24:1252.
    PubMed    
    Abstract available

  60. RAZAQ L, Uddin F, Alhilfi WA, Alorabi M, et al
    Molecular characterization of bla(NDM) and other carbapenemases genes among carbapenem-resistant Enterobacterales from community-and hospital- acquired urinary tract infections.
    BMC Infect Dis. 2025;25:1260.
    PubMed    
    Abstract available

  61. ASGHAR MU, Tariq M, Zaidi AH, Haneef K, et al
    Unveiling the spectrum of vancomycin resistance in Staphylococcus aureus from Hospital-acquired urinary tract infections (HA-UTI) in cardiac patients.
    Mol Biol Rep. 2025;52:1001.
    PubMed    
    Abstract available

  62. MARTINO L, Camporesi A, Lazzareschi I, Cascio G, et al
    Diagnostic multiparametric models and antibiotic practices in febrile infants younger than 90 days.
    Eur J Pediatr. 2025;184:669.
    PubMed    
    Abstract available

  63. JOHNSON EK, Shannon R, Walton RF, Rague JT, et al
    Phimosis Treatment and Recurrent Urinary Tract Infection Risk in Infants.
    Clin Pediatr (Phila). 2025 Oct 8:99228251382041. doi: 10.1177/00099228251382041.
    PubMed    


  64. BAUER HH, Villarreal EM, Rhodes SP, Hijaz AK, et al
    Risk of urinary tract infection after hysterectomy for benign indications based on antibiotic prophylaxis regimen.
    J Minim Invasive Gynecol. 2025 Oct 6:S1553-4650(25)00867.
    PubMed    
    Abstract available

  65. LI N, Shi R, Sun Y, Chen Q, et al
    Effective interventions to prevent catheter-associated urinary tract infections: a systematic review.
    Rev Inst Med Trop Sao Paulo. 2025;67:e61.
    PubMed    
    Abstract available

  66. GUILCAZO D, Lopez L, Calderon D, Vasquez K, et al
    Comparative Analysis of ESBL Phenotypes and Antimicrobial Resistance in Escherichia coli Associated with Urinary Tract Infections and in Commensal Strains.
    Microb Drug Resist. 2025 Oct 7. doi: 10.1177/10766294251386346.
    PubMed    
    Abstract available

  67. BALLASH GA, Diaz-Campos D, Van-Balen Rubio J, Mollenkopf DF, et al
    Escherichia coli causing urinary tract infections in dogs and humans differ in population structure and pathogenic potential: a comparative genomic analysis.
    Am J Vet Res. 2025 Oct 7:1-12. doi: 10.2460/ajvr.25.05.0177.
    PubMed    
    Abstract available

  68. BUDDHASIRI S, Tantibhadrasapa A, Mongkolkarvin P, Sukjoi C, et al
    Draft genome sequences of extended-spectrum beta-lactamase-producing uropathogenic Escherichia coli strains isolated from patients with urinary tract infections.
    Microbiol Resour Announc. 2025 Oct 7:e0081425. doi: 10.1128/mra.00814.
    PubMed    
    Abstract available

  69. ROBINO L, Navarro N, Canales-Huerta N, Gonzalez MJ, et al
    Urogenital microbiome, intracellular bacterial communities, and their contribution to urinary tract infections.
    Microbiol Spectr. 2025 Oct 7:e0124725. doi: 10.1128/spectrum.01247.
    PubMed    
    Abstract available

  70. SRIVASTAVA S, Roddam S, Srivastava D, Shehu A, et al
    Exploring Non-antibiotic Interventions for Preventing Urinary Tract Infections During Pregnancy: A Systematic Review.
    Cureus. 2025;17:e93874.
    PubMed    
    Abstract available

  71. MIRSHARIFI S, Habibi M, Rahimi T, Foroohi F, et al
    Design and Assessment of the Immunogenic Potential of a Multi-Peptide Vaccine Construct Against Uropathogenic Escherichia coli-Associated Urinary Tract Infection.
    Iran Biomed J. 2025;29.
    PubMed    
    Abstract available

  72. WINZEY KD, Scott L, Moreira D, Islam TS, et al
    Antimicrobial treatment ameliorates delirium-like phenotypes in a murine model of urinary tract infection.
    Transl Psychiatry. 2025;15:360.
    PubMed    
    Abstract available

  73. POTKONJAK AM, Terzic I, Lovric M, Gall V, et al
    ETIOLOGY OF URINARY TRACT INFECTIONS IN NEONATES AND BACTERIAL RESISTANCE IN CROATIA.
    Acta Clin Croat. 2024;63.
    PubMed    
    Abstract available

  74. HATAMLEH R, Al-Akour N, Al-Bakheet W, Atout M, et al
    Urinary tract infection among primigravid singleton pregnancies: a retrospective study from the North of Jordan.
    Front Glob Womens Health. 2025;6:1654691.
    PubMed    
    Abstract available

  75. DI Y, Zhang L, Zhao L, Yin L, et al
    Influencing Factors and Risk Prediction Model Construction of Urinary Tract Infections in Patients with Bladder Cancer.
    Res Rep Urol. 2025;17:383-399.
    PubMed    
    Abstract available

  76. ARIVALAGAN B, Qureshi Z, Vashisht R, Nasr R, et al
    Asymptomatic urinary tract infection manifesting as purple urine.
    Indian J Med Microbiol. 2025 Oct 2:100986. doi: 10.1016/j.ijmmb.2025.100986.
    PubMed    
    Abstract available

  77. SCHWARZTUCH GILDOR O, Yosef E, Levin N, Itshak A, et al
    Does SUFU's best practice policy statement regarding antibiotic prophylaxis predict urinary tract infection after urodynamic study? : Evidence from a retrospective cohort.
    World J Urol. 2025;43:596.
    PubMed    
    Abstract available

  78. MAITI KS, Roy S, Zenner C, J Hall L, et al
    Infrared Spectroscopic Profiling of Volatile Metabolites from Uropathogenic Bacteria: Basic Investigations toward Rapid UTI Diagnostics.
    Anal Chem. 2025;97:21449-21458.
    PubMed    
    Abstract available

  79. GHAFFARI LASHKENARI E, Mir MS, Mohammadi M, Javadi K, et al
    Investigating the Relationship Between Mutations in gyrA and parC Genes and Resistance to Fluoroquinolones in Uropathogenic Escherichia coli Isolates.
    Microb Drug Resist. 2025;31:317-322.
    PubMed    
    Abstract available

  80. SHI XX, Rong LR, Wei HZ
    Screening of Relevant Genes and Signalling Pathways Affecting Adult Urosepsis: A Bioinformatic Analysis.
    Urol J. 2025;22:203-208.
    PubMed    
    Abstract available

  81. KAZEMI S, Mojtahedi A, Hosseini F
    Emergence of Escherichia coli sequence type 131 clone carrying bla(CTX-M) genes in Guilan Province, Northern Iran.
    Microbiol Spectr. 2025;13:e0227024.
    PubMed    
    Abstract available

  82. CHEN AY, Allison M, Puskarich M, Vilke GM, et al
    Risk factors associated with return sepsis admission following emergency department discharge with infection.
    Am J Emerg Med. 2025;97:207-215.
    PubMed    
    Abstract available

  83. GETANEH FW, Pennycuff JF, Kelly H, McCann H, et al
    Local Estrogen Adherence: A Prospective Pilot Study.
    J Womens Health (Larchmt). 2025;34:1240-1246.
    PubMed    
    Abstract available

  84. LE GOUX C, Bouiller K, Dinh A, Sotto A, et al
    Short CIAFU recommendations on the screening and management of asymptomatic bacteriuria in immunocompromised patients.
    Fr J Urol. 2025;35:102941.
    PubMed    
    Abstract available

  85. NARAYAN M, Mohapatra S, Das BK, Gautam H, et al
    Applicability of cascade reporting among the uropathogens from a tertiary healthcare center: A pilot study targeting antimicrobial stewardship intervention.
    Indian J Med Microbiol. 2025;57:100921.
    PubMed    
    Abstract available

  86. BERRON M, Daviet JC, Ladrat C, Salle JY, et al
    Neuro-urological monitoring of spinal cord injury patients in a physical medicine and rehabilitation department.
    Fr J Urol. 2025;35:102924.
    PubMed    
    Abstract available

  87. YAMAMOTO S, Fukuhara H, Kuroiwa H, Shigehisa R, et al
    Preoperative Pyuria as a Predictor of False-Positive Rates in the Photodynamic Diagnosis of Nonmuscle-Invasive Bladder Cancer Using Oral 5-Aminolevulinic Acid.
    Int J Urol. 2025 Jun 9. doi: 10.1111/iju.70134.
    PubMed    
    Abstract available

  88. ALGHAMDI A
    Evaluating antibiotic prescribing practices for patients with asymptomatic bacteriuria in Saudi Arabia: The need for stewardship initiatives.
    Infect Dis Health. 2025;30:322-326.
    PubMed    
    Abstract available

  89. WU MZ, Guo R, Chandramouli C, Liu L, et al
    Urinary tract infection and continuation of sodium-glucose cotransporter-2 inhibitors in diabetic patients.
    Eur Heart J. 2025 Oct 17:ehaf788. doi: 10.1093.
    PubMed    
    Abstract available

  90. ELMIMOGHADDAM A, Vahidi M, Heidari R, Ghorbani M, et al
    Trichosporon Urinary Tract Infections: A Hidden Menace Revealed.
    Iran J Pathol. 2025;20:367-379.
    PubMed    
    Abstract available

  91. SUGIYAMA K, Hirai K, Kibe M, Fukumoto N, et al
    Resistance Patterns and Optimization of Empirical Therapy for Urinary Tract Infections in Patients on Trimethoprim-Sulfamethoxazole Prophylaxis Against Pneumocystis jirovecii.
    Microb Drug Resist. 2025 Oct 16. doi: 10.1177/10766294251388934.
    PubMed    
    Abstract available

  92. TRAILOKYA AA, Tiwaskar M
    Fosfomycin Tromethamine: A Urinary Antibiotic.
    J Assoc Physicians India. 2025;73:79-82.
    PubMed    
    Abstract available

  93. UCAMA JMS, Smith L, Pires J, Tomas P, et al
    Schistosomiasis and ruptured ectopic pregnancy: A case report.
    Womens Health (Lond). 2025;21:17455057251387469.
    PubMed    
    Abstract available

  94. ZAFAR MU, Hussain M, Hasan AS
    Prevalence of Urinary Tract Infection and Urosepsis Following Transrectal Ultrasound-Guided Prostate Biopsy: Spectrum of Pathogens and Patterns of Antibiotic Resistance.
    Cureus. 2025;17:e92218.
    PubMed    
    Abstract available

  95. ROSTINAWATI T, Aly FPR, Wicaksono IA, Febrina E, et al
    Exploring the TEM beta-Lactamase in E. coli From Urinary Tract Infection Patient: Insights From Molecular Docking and Dynamics Simulations.
    Infect Drug Resist. 2025;18:5277-5293.
    PubMed    
    Abstract available

  96. KRAWCZYK B, Wityk P
    The Role of Escherichia coli Autotransporters in Urinary Tract Infections and Urosepsis.
    Int J Mol Sci. 2025;26:9760.
    PubMed    
    Abstract available

  97. FERNANDEZ VECILLA D, Rodriguez Grande J, Fraile Valcarcel N, Roche Matheus MP, et al
    Genomic Characterization of a Rare K30-ST198 Hypervirulent Klebsiella pneumoniae Clone with Distinctive Virulence Features.
    Int J Mol Sci. 2025;26:9601.
    PubMed    
    Abstract available

  98. MASLENNIKOVA IL, Nekrasova IV, Starcic Erjavec M, Karimova NV, et al
    Uropathogenic Escherichia coli Biofilms: Antibiotic Pressure and Interaction with Human Neutrophils.
    Int J Mol Sci. 2025;26:9484.
    PubMed    
    Abstract available

  99. BAIMAKHANOVA B, Sadanov A, Berezin V, Baimakhanova G, et al
    Emerging Technologies for the Diagnosis of Urinary Tract Infections: Advances in Molecular Detection and Resistance Profiling.
    Diagnostics (Basel). 2025;15:2469.
    PubMed    
    Abstract available

  100. TIAN B, Chen C, Cheng J, Wang J, et al
    Predictors, trends and outcomes associated with urinary tract infections in intracerebral hemorrhage: insights from a National Inpatient Sample Study (2010-2022).
    Eur J Med Res. 2025;30:974.
    PubMed    
    Abstract available

  101. MAROYI R, Espoir CM, Chrispin UM, Gloire MN, et al
    Determinants of urogenital tract infection symptoms among adolescent girls and young women in secondary schools and universities in Bukavu, Democratic Republic of Congo: a cross-sectional study.
    BMC Womens Health. 2025;25:496.
    PubMed    
    Abstract available

  102. KUMARI C, Tariq T, Memon M
    New Era for Urinary Tract Infection Treatment: Gepotidacin Receives FDA Approval.
    Int Urogynecol J. 2025 Oct 15. doi: 10.1007/s00192-025-06388.
    PubMed    


  103. LEE SJ, Yoon H, Shin JC, Cho SR, et al
    Machine learning prediction of multidrug-resistant urinary tract infections in brain and spinal cord injury patients: a dual-center validation study.
    Int J Med Inform. 2025;206:106143.
    PubMed    
    Abstract available

  104. AMANDO BR, Sidrim JJC, Firmiano Gomes FI, Melgarejo CM, et al
    Chlorpromazine, impregnated in foley catheter fragments, as an antibiofilm agent to control urinary tract infections.
    Future Microbiol. 2025 Oct 14:1-9. doi: 10.1080/17460913.2025.2572902.
    PubMed    
    Abstract available

  105. NASR R, Mohamed Nasr S, Okasha H, Dahroug H, et al
    Investigating Molecular Biomarkers in E. coli-Induced Urinary Tract Infections: Insights into the Long Non-Coding RNAs Contribution to Antimicrobial Resistance.
    Recent Pat Biotechnol. 2025 Oct 6. doi: 10.2174/0118722083388214250924193840.
    PubMed    
    Abstract available

  106. ZHANG T, Zhao Y, Fan J, Shao Y, et al
    Incidence and risk factors of urinary tract infection in patients with spinal cord injury: a meta-analysis.
    Eur Spine J. 2025 Oct 14. doi: 10.1007/s00586-025-09337.
    PubMed    
    Abstract available

  107. BARTALUCCI C, Giurco M, Vena A, Giacobbe DR, et al
    Investigating cefepime/taniborbactam for the treatment of complicated urinary tract infections.
    Expert Opin Pharmacother. 2025 Oct 15:1-9. doi: 10.1080/14656566.2025.2574849.
    PubMed    
    Abstract available

  108. ASKARALI R, Vilvest J, Yagoo A, Vaishnika AM, et al
    Molecular characterization and antibacterial activity of colicin-producing Escherichia coli isolated from urinary tract infections.
    Folia Microbiol (Praha). 2025 Oct 13. doi: 10.1007/s12223-025-01368.
    PubMed    
    Abstract available

  109. ZUO X, Fang C, Wang C, Fang Z, et al
    Global trends in childhood urinary tract infections, 1990-2021: results from the GBD study.
    Front Public Health. 2025;13:1593206.
    PubMed    
    Abstract available

  110. WEI Y, Liu H, Jiang P, Wang S, et al
    Factors Associated with Stigma in Adult Women with Uncomplicated Urinary Tract Infections in China: A Cross-Sectional Study.
    Risk Manag Healthc Policy. 2025;18:3249-3262.
    PubMed    
    Abstract available

  111. RAOOF OH, Mutter TY, Ayvaz A
    Antimicrobial and anti-virulence effects of functionalized cobalt nanoparticles against multidrug-resistant Escherichia coli causing urinary tract infections.
    Microb Pathog. 2025;209:108101.
    PubMed    
    Abstract available

  112. TANGU NN, Nantia Akono E, Ngoufo FN, Tuekam Kayo RP, et al
    Prevalence and epidemiological factors associated with urogenital schistosomiasis amongst school children in three health districts of Cameroon; Lagdo (North), Loum and Njombe-Penja (Littoral): a cross-sectional study.
    BMC Infect Dis. 2025;25:1274.
    PubMed    
    Abstract available

  113. MDULUZA T, Zdesenko G, Tagwireyi P, Jones CM, et al
    Identifying hotspots of S. haematobium infection following praziquantel treatment during multiple annual mass drug administration campaigns in Zimbabwe.
    PLoS Negl Trop Dis. 2025;19:e0013546.
    PubMed    
    Abstract available

  114. OJASANYA RA, Weese JS, Sobkowich KE, Deckert A, et al
    Assessment of seasonality in antimicrobial susceptibility testing and resistance of urinary Escherichia coli from dogs and cats in the United States (2019 - 2022).
    Prev Vet Med. 2025;245:106684.
    PubMed    
    Abstract available

  115. BURGOS JG, Jirsova E, Kranz J, Bonkat G, et al
    A Call To Prevent Inappropriate Prescribing of Fluoroquinolones from the European Medicines Agency and the European Association of Urology Guidelines Panel for Urological Infections.
    Eur Urol. 2025;88:427-429.
    PubMed    
    Abstract available

  116. MADHAVAN K, Bhargava P, Phonde A, Yadav S, et al
    Preventing Infectious Complications Following Prostate Biopsy: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials of Alternative Approaches to Transrectal Biopsy with Empirical Antibiotic Prophylaxis Therapy.
    Eur Urol Focus. 2025;11:301-311.
    PubMed    
    Abstract available

  117. HERNANDEZ-ALOMIA F, Bastidas-Caldes C, Zambrano A, Narvaez M, et al
    Molecular characterization of antimicrobial resistance genes and plasmid profiles in enterobacterales isolated from urinary tract infections in rural outpatient women in Otavalo, Ecuador.
    BMC Infect Dis. 2025;25:1397.
    PubMed    
    Abstract available

  118. AZIZ M, Park DE, Quinlivan V, Dimopoulos EA, et al
    Zoonotic Escherichia coli and urinary tract infections in Southern California.
    mBio. 2025 Oct 23:e0142825. doi: 10.1128/mbio.01428.
    PubMed    
    Abstract available

  119. MALEKZADEGAN Y, Abdi A, Khashei R
    Distribution of serogroup and pathogenicity Island markers of uropathogenic Escherichia coli from inpatients in a tertiary care hospital.
    BMC Res Notes. 2025;18:440.
    PubMed    
    Abstract available

  120. YANG S, Liu Y, Zhang J, Xu J, et al
    An integrated lab-in-a-tube platform for point-of-care detection of bla(KPC) in urinary tract infections.
    Mikrochim Acta. 2025;192:748.
    PubMed    
    Abstract available

  121. ELBAHR U, Khairy A, Dayyab F, Delos Reyes CS, et al
    Caspofungin in the treatment of Candida auris candiduria in Hemato-oncological Patients: An observational retrospective cohort study.
    New Microbiol. 2025;48:155-159.
    PubMed    
    Abstract available

  122. ALZAIDI E, Alshammari M, AlKhulaifi M, Alrashidi B, et al
    Detection of Integrons in Escherichia coli Associated With Urinary Tract Infections in Riyadh, Saudi Arabia.
    Int J Microbiol. 2025;2025:1013136.
    PubMed    
    Abstract available

  123. MUKHERJEE K, Aschenbach W, Hilger A, Saur J, et al
    Differential perception of virulence factors of uropathogenic Escherichia coli at the level of chromatin dynamics of infected host cells.
    Front Immunol. 2025;16:1642683.
    PubMed    
    Abstract available

  124. GALVAO VS, Souza Santos Monteiro A, Leite JLP, Sousa IO, et al
    High Rates of Antimicrobial Resistance and Emergence of High-Risk Clones in Community-Acquired Uropathogenic Escherichia coli.
    Microbiologyopen. 2025;14:e70074.
    PubMed    
    Abstract available

  125. LUKKUNAPRASIT T, Tansawet A, Siriyotha S, Looareesuwan P, et al
    Effects of sodium-glucose co-transporter-2 inhibitors on the risk of nephrolithiasis and urinary tract infections in Thai patients with type 2 diabetes: a hospital-based cohort study.
    Diabetol Metab Syndr. 2025;17:400.
    PubMed    
    Abstract available

  126. BELMONT C, Inamdar P, Shariff-Marco S, Gul A, et al
    Spatial clusters of dominant lineages of uropathogenic Escherichia coli in a community dwelling patient population.
    BMC Infect Dis. 2025;25:1379.
    PubMed    
    Abstract available

  127. THEUT M, Jonsson A, Jensen JN, Antsupova V, et al
    Factors influencing urinary tract infection prevention and antibiotic stewardship in European nursing homes: an interview study with staff.
    Eur Geriatr Med. 2025 Oct 21. doi: 10.1007/s41999-025-01330.
    PubMed    
    Abstract available

  128. BANGURA M, Malani PN, Solway E, Kirch M, et al
    Self-reported urinary tract infections in the past year among perimenopausal and postmenopausal women: a nationally representative survey.
    Menopause. 2025 Oct 14. doi: 10.1097/GME.0000000000002668.
    PubMed    
    Abstract available

  129. MEZZASALMA N, Spadini C, Rega M, Montanaro SL, et al
    Genomic tracing and resolution of environmental Klebsiella pneumoniae ST307 CTX-M-15 linked to a nosocomial urinary tract infection in a cat: a veterinary teaching hospital case study.
    BMC Vet Res. 2025;21:618.
    PubMed    
    Abstract available

  130. MIR TA, Shareef T, Lone SA, Mir SA, et al
    Antibiotic Resistance Profiling and Identification of Risk Factors Associated With Prevalence of Urinary Tract Infections: A Cross-Sectional Study.
    APMIS. 2025;133:e70074.
    PubMed    
    Abstract available

  131. KAUR H, Chauhan S, Yadav M
    SGLT2 Inhibitors and Complicated Urinary Tract Infections: A Rare Case of Emphysematous Pyelonephritis and Subsequent Recurrence Associated With Dapagliflozin Use.
    Clin Case Rep. 2025;13:e71320.
    PubMed    
    Abstract available

  132. HUZAIFA M
    Optimizing antibiotic strategies for recurrent urinary tract infection in menopausal women: Extended therapy versus prophylaxis.
    Indian J Urol. 2025;41:319-320.
    PubMed    


  133. AHMAD KHAN Z, Ahmad I, Ashraf
    High-Sensitivity C-reactive Protein (hs-CRP) as a Biomarker for Predicting Urinary Tract Infection (UTI) Severity and Associated Complications.
    Cureus. 2025;17:e91803.
    PubMed    
    Abstract available

  134. ALSHAMMARI D, Banu SS, Yadav P
    Recent Advances in Paediatric Vesicoureteral Reflux: Risk Assessment and Management Strategies.
    Arch Esp Urol. 2025;78:956-966.
    PubMed    
    Abstract available

  135. SAGLAM MK, Yanasoglu E, Sav NM, Kurt F, et al
    The rising threat of antibiotic and multidrug resistance in neonatal urinary tract infections.
    BMC Pediatr. 2025;25:824.
    PubMed    
    Abstract available

  136. GUPTE V, Sawant S, Mohanasundaram S, Malabade R, et al
    Plazomicin Pharmacokinetics in Indian Complicated Urinary Tract Infections Patients: A Subgroup Analysis From Phase 2 Study.
    Clin Pharmacol Drug Dev. 2025 Oct 19. doi: 10.1002/cpdd.1616.
    PubMed    
    Abstract available

  137. YAMAMOTO S, Fujii K, Kayama Y, Nimura A, et al
    Oral gepotidacin for the treatment of uncomplicated urinary tract infection in Japanese female patients: a randomized, active reference, double-blind, double-dummy, Phase 3 trial (EAGLE-J).
    J Infect Chemother. 2025 Oct 16:102829. doi: 10.1016/j.jiac.2025.102829.
    PubMed    
    Abstract available

  138. PORTO BC, Almeida AS, Terada BD, Goncalves FG, et al
    Uro-vaxom (OM-89) for chronic UTI prevention: an updated meta-analysis, meta-regression and trial sequential analysis of recent clinical evidence.
    Minerva Urol Nephrol. 2025;77:618-628.
    PubMed    
    Abstract available

  139. PEYKO V, Sieger J, Dombroski J
    Single-Dose Gentamicin vs Standard Care for Treatment of Acute Uncomplicated Cystitis in Premenopausal Women: A Randomized Trial.
    J Pharm Pract. 2025;38:518-524.
    PubMed    
    Abstract available

  140. ALONSO-CADENAS JA, Gomez B, Velasco R, Suarez-Bustamante Huelamo M, et al
    Urine culture findings in well-appearing febrile infants aged 22-90 days with negative urinalysis.
    Arch Dis Child. 2025 Jun 6:archdischild-2025-328637.
    PubMed    
    Abstract available

  141. IACHKINE J, Alexandre K, Marlat C, Briant A, et al
    Temocillin versus other intravenous beta-lactams for urinary tract infections caused by third-generation cephalosporin-resistant Enterobacterales: a multicentre retrospective matched cohort study.
    J Antimicrob Chemother. 2025 Sep 30:dkaf370. doi: 10.1093.
    PubMed    
    Abstract available

  142. LARKIN C, Valappil SP, Palanisamy N
    Global prevalence of nitrofurantoin-resistant uropathogenic Escherichia coli (UPEC) in humans: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2025;80:2609-2621.
    PubMed    
    Abstract available

  143. KOENIG C, Yi F, Nicolau DP, Asempa TE, et al
    In vivo activity of ceftibuten-ledaborbactam oral combination against serine-beta-lactamase-producing Enterobacterales: an assessment in the pyelonephritis and cystitis murine model.
    J Antimicrob Chemother. 2025;80:2714-2718.
    PubMed    
    Abstract available

  144. ABDULFATTAH S, Kye NJ, Shah AP, Eftekharzadeh S, et al
    A Risk Stratification Model to Predict Febrile Urinary Tract Infection After Cessation of Continuous Antibiotic Prophylaxis in Children with Known Vesicoureteral Reflux.
    J Urol. 2025 Oct 10:101097JU0000000000004815. doi: 10.1097/JU.0000000000004815.
    PubMed    
    Abstract available

  145. RICKARD M, Lorenzo AJ, Robinson C, Maher S, et al
    Impact of a standardized care pathway and a dedicated multidisciplinary posterior urethral valve clinic on 5-year kidney and bladder outcomes.
    Pediatr Nephrol. 2025;40:3459-3467.
    PubMed    
    Abstract available

  146. SENGAR M, Damdoo A, Khan N, Gupta CR, et al
    Renal perfusion in dynamic scans: a key predictor of long-term outcomes in posterior urethral valves.
    Pediatr Nephrol. 2025;40:3687-3695.
    PubMed    
    Abstract available

  147. BRUINS MJ, Eijkelkamp-Biesterbos L, Meutstege AM, Dos Santos CO, et al
    Escherichia coli antimicrobial resistance in acute urinary tract infection lower than reported in Dutch national surveillance database.
    PLoS One. 2025;20:e0334222.
    PubMed    
    Abstract available

  148. KUROTSCHKA PK, Koch MJ, Bucher E, Figueiras A, et al
    Dipsticks and point-of-care Microscopy in Urinary Tract Infections in primary care: Results of the MicUTI pilot cluster randomised controlled trial.
    PLoS One. 2025;20:e0332390.
    PubMed    
    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Urinary Tract Infection is free of charge.


;